Stock LABP LANDOS BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Landos Biopharma, Inc.

Equities

LABP

US5150692011

Market Closed - Nasdaq
Other stock markets
 16:30:01 2024-04-29 EDT 		5-day change 1st Jan Change
22.48 USD +0.76% Intraday chart for Landos Biopharma, Inc. +2.37% +514.20%
04-02 North American Morning Briefing : Stocks Seen -2- DJ
04-01 HC Wainwright Downgrades Landos Biopharma to Neutral From Buy MT

Evolution of the average Target Price on Landos Biopharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

79c59c3c5069d42a61bcf3a9ea1ae95e.vzjLISpQKE51bzP_dMcZrMtyRFtjFUWCHYxvOJMhVxg.h0CZFEggRXcWJUa2P_FL3YlfEQ8rdDbdZ_gDaNoVD3zVb5NwYj9PNCcWfg~1fd614b28e3a7ec1e49d1e01a9a3912f

Analyst Recommendations on Landos Biopharma, Inc.

HC Wainwright Downgrades Landos Biopharma to Neutral From Buy MT
Jefferies Downgrades Landos Biopharma to Underperform From Hold, Cuts Price Target to $0.10 From $0.20 MT
SVB Securities Adjusts Landos Biopharma's Price Target to $3 from $16, Maintains Market Perform Rating MT
Raymond James Downgrades Landos Biopharma to Market Perform From Outperform MT
Jefferies Downgrades Landos Biopharma to Hold From Buy, Adjusts Price Target to $1.40 From $30 MT
Raymond James Adjusts Landos Biopharma's Price Target to $9 From $24, Keeps Outperform Rating MT
JPMorgan Adjusts Price Target on Landos Biopharma to $7 From $15, Maintains Neutral Rating MT
Craig-Hallum Adjusts Landos Biopharma's Price Target to $29.50 From $45, Reiterates Buy Rating MT
Jones Trading Downgrades Landos Biopharma to Hold From Buy MT
SVB Leerink Downgrades Landos Biopharma to Market Perform from Outperform, Adjusts Price Target to $16 from $20 MT
LANDOS BIOPHARMA : Craig-Hallum Starts Landos Biopharma at Buy with $45 Price Target MT
LANDOS BIOPHARMA : HC Wainwright Starts Landos Biopharma at Buy With $50 Price Target MT
LANDOS BIOPHARMA : Jones Trading Starts Landos Biopharma at Buy with $39 Price Target MT
LANDOS BIOPHARMA : JPMorgan Starts Landos Biopharma at Neutral With $17 Price Target MT
LANDOS BIOPHARMA : Jefferies Starts Landos Biopharma at Buy With $32 Price Target MT
LANDOS BIOPHARMA : Raymond James Starts Landos Biopharma at Outperform With $33 Price Target MT
LANDOS BIOPHARMA : SVB Leerink Starts Landos Biopharma at Outperform With $20 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
22.48 USD
Average target price
12.71 USD
Spread / Average Target
-43.46%
High Price Target
20.42 USD
Spread / Highest target
-9.16%
Low Price Target
5 USD
Spread / Lowest Target
-77.76%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Landos Biopharma, Inc.

HC Wainwright
Jefferies & Co.
Raymond James
SVB Securities LLC
JPMorgan Chase
Craig-Hallum
SVB Leerink
JonesTrading Institutional Services
J.P. Morgan Chase

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. LABP Stock
  4. Consensus Landos Biopharma, Inc.